Individualization of interferon therapy using serum hepatitis B virus DNA to reduce viral relapse in patients with chronic hepatitis B: a randomized controlled trial

No abstract is available for this paper.

• Publication year

  2003

• Venue

  European Journal of Gastroenterology and Hepathology

• Publication date

  2003-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/01.meg.0000059120.41030.52PMID 12702905
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hepatitis B infection: pathogenesis and management.

  2000cited by this paper
• Antiviral chemotherapy for the treatment of hepatitis B virus infections.

  2000cited by this paper
• Interferon alfa for chronic hepatitis B infection: Increased efficacy of prolonged treatment

  1999cited by this paper
• Long‐term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection

  1999cited by this paper
• Long-term follow-up of patients with chronic hepatitis B treated with interferon alfa.

  1997cited by this paper
• Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B.

  1996cited by this paper
• Hepatitis B virus immunopathogenesis.

  1995cited by this paper
• Molecular diagnostic techniques for viral hepatitis.

  1994cited by this paper
• Antiviral Therapy of the Asian Patient with Chronic Hepatitis B

  1993cited by this paper
• Long-term follow-up of chronic hepatitis B patients treated with interferon alfa.

  1993cited by this paper
• A randomized, controlled trial of recombinant alpha-interferon therapy for chronic hepatitis B.

  1993cited by this paper
• Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

  1993cited by this paper
• Antiviral effect of prolonged intermittent lymphoblastoid alpha interferon treatment in chronic hepatitis B.

  1992cited by this paper
• Demonstration of hepatitis B virus DNA by polymerase chain reaction in the serum and the liver after spontaneous or therapeutically induced HBeAg to anti‐HBe or HBsAg to Anti‐HBs seroconversion in patients with chronic hepatitis B

  1992cited by this paper
• Long-term remission of chronic hepatitis B after alpha-interferon therapy.

  1991cited by this paper
• Interferon alfa therapy in patients with chronic hepatitis B virus infection. Effects on hepatitis B virus DNA in the liver.

  1991cited by this paper
• In hepatocytes infected with duck hepatitis B virus, the template for viral RNA synthesis is amplified by an intracellular pathway.

  1990cited by this paper
• A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group.

  1990cited by this paper
• A Randomized, Controlled Trial of Interferon Alfa-2b Alone and after Prednisone Withdrawal for the Treatment of Chronic Hepatitis B

  1990cited by this paper
• Detection of serum hepatitis B virus DNA in patients with chronic hepatitis using the polymerase chain reaction assay.

  1989cited by this paper
• Which patients with chronic hepatitis B virus infection will respond to α‐interferon therapy? A statistical analysis of predictive factors

  1989cited by this paper
• Long-term follow-up in a randomised controlled trial of recombinant alpha 2-interferon in Chinese patients with chronic hepatitis B infection.

  1988cited by this paper
• LONG-TERM FOLLOW-UP IN A RANDOMISED CONTROLLED TRIAL OF RECOMBINANT α2-INTERFERON IN CHINESE PATIENTS WITH CHRONIC HEPATITIS B INFECTION

  1988cited by this paper
• Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B.

  1988cited by this paper
• Hepatitis B virus deoxyribonucleic acid in liver of chronic carriers. Correlation with serum markers and changes associated with loss of hepatitis B e antigen after antiviral therapy.

  1987cited by this paper
• Hepatitis B virus DNA in the sera of HBsAg carriers: A marker of active hepatitis B virus replication in the liver

  1981cited by this paper

• Systematic Review of the Literature on Comparative Effectiveness of Antiviral Treatments for Chronic Hepatitis B Infection

  2011cites this paper
• Antiviral Therapy for Adults With Chronic Hepatitis B: A Systematic Review for a National Institutes of Health Consensus Development Conference

  2009cites this paper
• Demonstration of an association between detection of IgG antibody reactivity towards the C‐terminal region of the preS1 protein of hepatitis B virus and the capacity to respond to interferon therapy in chronic hepatitis B

  2008cites this paper
• Treating chronic hepatitis B: today and tomorrow.

  2006cites this paper
• Combination of alpha-interferon with lamivudine reduces viral breakthrough during long-term therapy.

  2004cites this paper
• Combination of α‐interferon with lamivudine reduces viral breakthrough during long‐term therapy

  2004cites this paper
• PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version

  2001cites this paper